ADHERENCE TO GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS IMMUNOPROPHYLAXIS AMONG INFANTS WITH PREMATURITY OR CHRONIC LUNG DISEASE IN THREE UNITED STATES COUNTIES

被引：5

作者：

Carroll, Kecia N. ^{[1
]}

Griffin, Marie R. ^{[2
,3
]}

Edwards, Kathryn M.

Ali, Asad

Zhu, Yuwei ^{[4
]}

Iwane, Marika K. ^{[5
]}

Szilagyi, Peter G. ^{[6
]}

Staat, Mary A. ^{[7
]}

Stevens, Timothy P. ^{[6
]}

Hall, Caroline B. ^{[6
]}

Williams, John V. ^{[8
]}

Hartert, Tina V. ^{[3
]}

机构：

[1] Vanderbilt Univ, Div Gen Pediat, Sch Med, Dept Pediat, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Dept Prevent Med, Sch Med, Nashville, TN 37232 USA

[3] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37232 USA

[4] Vanderbilt Univ, Dept Biostat, Sch Med, Nashville, TN 37232 USA

[5] Ctr Dis Control & Prevent, Atlanta, GA USA

[6] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA

[7] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA

[8] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2012年 / 31卷 / 11期

关键词：

respiratory syncytial virus; adherence; palivizumab; YOUNG-CHILDREN; PALIVIZUMAB; INFECTION; HOSPITALIZATIONS; PREVENTION;

D O I：

10.1097/INF.0b013e318266bf89

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

Among infants with prematurity and/or chronic lung disease for whom respiratory syncytial virus immunoprophylaxis is recommended, we examined adherence in infants enrolled during healthcare visits for acute respiratory illness in 3 US counties from 2001 to 2007. Immunoprophylaxis among infants who met national criteria for prophylaxis increased from 33% to 83% over the 6-year period; 17% (11/65) of infants who received immunoprophylaxis did not meet eligibility criteria.

引用

页码：E229 / E231

页数：3

共 12 条

[1]

Abramson JS, 2003, PEDIATRICS, V112, P1442

[2]

The effect of an interventional program on adherence to the American Academy of Pediatrics guidelines for palivizumab prophylaxis [J].

Afghani, Behnoosh ;

Ngo, Thienkim ;

Leu, Szu-Yun ;

Wu, Fu L. ;

Cecilio, Maricel ;

Aron-Johnson, Pamela ;

Zeitany, Raja ;

Sills, Jack ;

Amin, Alpesh .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (11) :1019-1024

[3]

*AM AC PED COMM IN, 2006, RED BOOK REP COMM IN

[4]

Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid [J].

Boyce, TG ;

Mellen, BG ;

Mitchel, EF ;

Wright, PF ;

Griffin, MR .

JOURNAL OF PEDIATRICS, 2000, 137 (06) :865-870

[5]

A Systematic Review of Compliance with Palivizumab Administration for RSV Immunoprophylaxis [J].

Frogel, Michael P. ;

Stewart, Dan L. ;

Hoopes, Michael ;

Fernandes, Ancilla W. ;

Mahadevia, Parthiv J. .

JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (01) :46-58

[6]

Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64

[7]

The Burden of Respiratory Syncytial Virus Infection in Young Children [J].

Hall, Caroline Breese ;

Weinberg, Geoffrey A. ;

Iwane, Marika K. ;

Blumkin, Aaron K. ;

Edwards, Kathryn M. ;

Staat, Mary A. ;

Auinger, Peggy ;

Griffin, Marie R. ;

Poehling, Katherine A. ;

Erdman, Dean ;

Grijalva, Carlos G. ;

Zhu, Yuwei ;

Szilagyi, Peter .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06) :588-598

[8]

Halsey NA, 1998, PEDIATRICS, V102, P1211, DOI 10.1542/peds.102.5.1211

[9]

Palivizumab Utilization and Compliance: Trends in Respiratory Syncytial Virus Prophylaxis in Florida [J].

Hampp, Christian ;

Saidi, Arwa S. ;

Winterstein, Almut G. .

JOURNAL OF PEDIATRICS, 2010, 156 (06) :953-U130

[10]

Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587

← 1 2 →